Healthy Patients

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.

AMR Insights is for:

  • Medical Microbiologists, Infectiologists and other specialists
  • General Practitioners, Pharmacists
  • Infection Prevention Experts and nurses
  • Medical Docters and Caretakers in nursing homes
  • Managers and Labtechnicians of Microbiological Laboratories.

Latest Topics

  •   04 November 2020

    PhageBank™ Deployed in Texas Outbreak of Life-Threatening Carbapenem Resistant A. baumannii (CRAB) in COVID-19 Patients

    Eight COVID-19 + CRAB patients have received PhageBank™ therapy under FDA-approved emergency allowance, with more anticipated

  •   03 November 2020

    Hospital Floors Are Hotspot for Bacteria, Creating Route of Transfer to Patients

    The floors of hospital rooms are quickly and frequently contaminated with antibiotic-resistant bacteria within hours of patient admission, creating a route of transfer of potentially dangerous organisms to patients.

  •   26 October 2020

    Antimicrobial Resistant Infections in Livestock Can Affect Humans Too

    The threat of antimicrobial resistance has the potential to return us to a pre-antimicrobial era in which common infections are untreatable.


More news related to Healthy patients

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!